Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

This study has been completed.
Information provided by:
Gachon University Gil Medical Center Identifier:
First received: August 16, 2010
Last updated: August 18, 2010
Last verified: October 2009